India’s largest drugmaker Sun Pharmaceutical Industries Ltd said it had received a warning letter from the US Food and Drug Administration for violating manufacturing standards at its Halol plant in western India. The warning indicates the agency is not satisfied with the remedial measures Sun Pharma has been taking at the plant since last September …

Sun Pharma Announces US FDA Filing Acceptance of Biologics License Application (BLA) For Tildrakizumab

Sun Pharmaceutical Industries Ltd has informed BSE that one of the Company's wholly-owned subsidiaries has voluntarily

Sun Pharmaceutical Industries (Sun Pharma) has received the order passed by National Company Law Tribunal (NCLT) at Ahmedabad bench in the matter of Scheme

Sun Pharmaceutical Industries Ltd announced that one of its subsidiaries has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Gleevec , Imatinib Mesylate tablets 100mg and 400mg Imatinib Mesylate tablets,

Sun Pharmaceutical Industries Ltd announced that one of its subsidiaries has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Gleevec , Imatinib Mesylate tablets and Imatinib Mesylate tablets,

Sun Pharmaceutical Industries Ltd posted a net profit of Rs. 17136.90 million for the quarter ended March 31, 2016 where as the same was at Rs. 8892.40 - See more at: http://ways2capital-equitytips.blogspot.in/2016/05/sun-pharma-q4-net-profit-at-rs1713690-mn.html#sthash.V5x4pKck.dpuf

Medical professional’s wits against the genes of bacteria: The world’s newest threat, antibiotic resistant bugs, with the unaffectionate sobriquet ‘superbugs,’ are getting the better of the medical and pharmaceutical fraternity.

Sun Pharmaceutical Industries rose 1.85% to Rs 543 at 9:58 IST on BSE after the company said one of its wholly-owned subsidiaries received US drug regulator's approval for generic Zetia tablets.

Sun Pharma rises after USFDA approval for generic drug : 13 June 2017

Sun Pharma, India's largest drug maker on Tuesday, said it has entered into a strategic agreement with Samsung BioLogics to manufacture the former's psoriasis drug Tildrakizumab.

Infografik Dilip Shanghvi: Geschäftsführer des indischen Sun Pharmaceuticals, dem größten Farma-Unternehmen in Indien und dem fünftgrößten weltweit.

Infografik Dilip Shanghvi: Geschäftsführer des indischen Sun Pharmaceuticals, dem größten Farma-Unternehmen in Indien und dem fünftgrößten weltweit.

Sun Pharmaceutical Industries Ltd. has recalled 68,000 bottles of the antidepressant Effexor in the U.S., in the second recall of the drug this year, the U.S. Food and Drug Administration said http://online.wsj.com/articles/sun-pharma-recalls-effexor-in-u-s-1416297616?mod=WSJ_LatestHeadlines

Sun Pharma Recalls Effexor in U.S.

A man carrying a gas cylinder walks out of the research and development centre of Sun Pharmaceutical Industries in Mumbai.

"Global Oxcarbazepine (CAS 28721-07-5) Market 2016 – Novartis, Taj Pharmaceuticals, Euticals, CTX Lifesciences, Sun Pharmaceutical, Jubilant, Zhejiang Jiuzhou, Langfang Gaobo, Hubei Gedian Humanwell" published by "theneighborhooduk" on @edocr

edocr is the only document marketplace to facilitate free lead generation, SEO visibility, and document selling.

Sun Pharmaceutical Industries Ltd ended 2.8% higher at Rs. 777.3 after the US drug regulator gave a green signal to the company’s generic Gleevec drug.

Researchers have found that a number of existing drugs approved for the treatment of various conditions show promise as antibiotic agents.

Sun Pharmaceuticals Becomes Asia's Largest Pharmaceutical Company   #Pharmaceutical #AsianMarket #SunPharmaceuticals #AsiaOne #AsiaOneNews #AsiaOneMagazine #AsiaNews

Sun Pharmaceuticals Becomes Asia's Largest Pharmaceutical Company #Pharmaceutical #AsianMarket #SunPharmaceuticals #AsiaOne #AsiaOneNews #AsiaOneMagazine #AsiaNews

Drug major Sun Pharmaceutical Industries on Wednesday said it has received approval from the US health regulator for its new drug application for acne treatment medicine--XiminoTM extended-release capsules. - See more at: http://ways2capital-review.blogspot.in/2015/08/sun-pharma-gets-usfda-approval-for-acne.html#sthash.OBisNDqH.dpuf

Drug major Sun Pharmaceutical Industries on Wednesday said it has received approval from the US health regulator for its new drug application for acne treatment medicine--XiminoTM extended-release capsules.

Sun Pharma completes divestment of 7 brands to RPG Life  :Drug major Sun Pharmaceutical Industries today completed the divestment of its seven prescription brands in India to RPG Life Sciences.

Chemotherapy is the terminology given to the form of medical treatment which is given to cancer patients. The drugs are called as chemotherapeutic drugs.

Капли для роста ресниц Sun Pharmaceuticals, India Карепрост (Биматопрост) - «ОБНОВЛЕНИЕ 25 августа! Спустя 5 месяцев! Забыла, что такое накладные ресницы (3 месяца использования + фото) » | Отзывы покупателей

Капли для роста ресниц Sun Pharmaceuticals, India Карепрост (Биматопрост) - «ОБНОВЛЕНИЕ 25 августа! Спустя 5 месяцев! Забыла, что такое накладные ресницы (3 месяца использования + фото) » | Отзывы покупателей

Dilip Sanghvi Net Worth and Biography

Top 10 Facts About Dilip ShanghviOpened a research and development center, which is credited as the first of its kind in the country opened in 19

BRAIN TUMORS, CELL PHONES, $$  - Malignant Glioma Market Poised to Expand at a Robust Pace Over 2016-2022 | Medgadget, 2.22.17 ...The major players in the Malignant Glioma Market are Sigma-Aldrich, Bristol-Myers, Genentech, Sun Pharmaceutical, Cipla, Panacea Biotec, Zydus Cadila and Merck. The largest market share is gained by the U.S, large incidence and prevalence of cases... 1 in 2 men and 1 in 3 women... almost 40% of the population are at a risk of developing cancer in coming years.

Malignant Glioma Market Poised to Expand at a Robust Pace Over 2016 - 2022

Pinterest
Search